Search results
Results from the WOW.Com Content Network
The company will need to demonstrate why its DNA based approach is “superior.” ... the average price target of $26.50 implies 31% upside from current levels. (See Inovio stock-price forecast ...
It has also raised its dividends for nine years in a row, which makes it one of the best dividend stocks on our list. The company currently offers $0.1525 per share in quarterly dividends, with a ...
Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
[4] [23] Inovio has partnerships with manufacturers to scale up production of a vaccine if preliminary efficacy trials are successful. [18] In April 2020, the company began human Phase I safety studies of its lead vaccine (INO-4800) in the United States, and a Phase I-II trial in South Korea, to test for immunization against the COVID-19 virus.
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
Dividend-growth shipping stocks like Costamare (CMRE) and Genco (GNK) are in investors' good books for the handsome rewards they provide, especially in the current uncertain scenario.
Inovio Pharmaceuticals (NASDAQ:INO) is heating up, as investors continue to flock to certain stocks for the novel coronavirus. Shares of INO stock have rallied 140% from the April 15 low to the ...